These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 27076109)
1. High rate of colistin dependence in Acinetobacter baumannii. Hong YK; Lee JY; Wi YM; Ko KS J Antimicrob Chemother; 2016 Aug; 71(8):2346-8. PubMed ID: 27076109 [No Abstract] [Full Text] [Related]
2. Variation in formation of persister cells against colistin in Acinetobacter baumannii isolates and its relationship with treatment failure. Chung ES; Wi YM; Ko KS J Antimicrob Chemother; 2017 Jul; 72(7):2133-2135. PubMed ID: 28379382 [No Abstract] [Full Text] [Related]
3. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070 [No Abstract] [Full Text] [Related]
4. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Cai Y; Chai D; Wang R; Liang B; Bai N J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575 [TBL] [Abstract][Full Text] [Related]
5. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients. Vourli S; Frantzeskaki F; Meletiadis J; Stournara L; Armaganidis A; Zerva L; Dimopoulos G Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317 [No Abstract] [Full Text] [Related]
6. Investigation of Colistin and Sulbactam Combination Effectivity in Multi Drug Resistant Acinetobacter baumannii Strains with Diagonal Gradient Strip Test Method. Hatipoglu H; Kilbas I; Kilic U; Yilmaz K; Koroglu M; Altindis M Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549991 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [TBL] [Abstract][Full Text] [Related]
8. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy. Hawley JS; Murray CK; Jorgensen JH Antimicrob Agents Chemother; 2008 Jan; 52(1):351-2. PubMed ID: 17954699 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria. Hamzeh AR; Al Najjar M; Mahfoud M Am J Infect Control; 2012 Oct; 40(8):776-7. PubMed ID: 22305413 [TBL] [Abstract][Full Text] [Related]
10. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia. Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246 [TBL] [Abstract][Full Text] [Related]
11. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166 [TBL] [Abstract][Full Text] [Related]
13. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii. Ozbek B; Sentürk A Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
15. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377 [TBL] [Abstract][Full Text] [Related]
16. Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat. Gupta M; Lakhina K; Kamath A; Vandana KE; Mukhopadhyay C; Vidyasagar S; Varma M J Hosp Infect; 2016 Sep; 94(1):72-3. PubMed ID: 27238611 [No Abstract] [Full Text] [Related]
17. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
18. Intensified infection control measures to minimize the spread of colistin-resistant Acinetobacter baumannii. Apisarnthanarak A; Rujanavech S; Luxamesathaporn P; Mundy LM Infect Control Hosp Epidemiol; 2013 Apr; 34(4):445-7. PubMed ID: 23466925 [No Abstract] [Full Text] [Related]
19. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Durante-Mangoni E; Zarrilli R Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942 [TBL] [Abstract][Full Text] [Related]
20. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Sirijatuphat R; Thamlikitkul V Antimicrob Agents Chemother; 2014 Sep; 58(9):5598-601. PubMed ID: 24982065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]